File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: The indirect impact of the COVID-19 pandemic on people with type 2 diabetes mellitus and without COVID-19 infection: Systematic review and meta-analysis

TitleThe indirect impact of the COVID-19 pandemic on people with type 2 diabetes mellitus and without COVID-19 infection: Systematic review and meta-analysis
Authors
KeywordsCOVID-19
Hemoglobin A1c
Indirect effect
Meta-analysis
Systematic review
Type 2 diabetes mellitus
Issue Date1-Mar-2023
PublisherElsevier
Citation
Primary Care Diabetes, 2023, v. 17, n. 3, p. 229-237 How to Cite?
Abstract

Background

The effect directly from the coronavirus disease 2019 (COVID-19) infection on health and fatality has received considerable attention, particularly among people with type 2 diabetes mellitus (T2DM). However, evidence on the indirect impact of disrupted healthcare services during the pandemic on people with T2DM is limited. This systematic review aims to assess the indirect impact of the pandemic on the metabolic management of T2DM people without a history of COVID-19 infection.

Methods

PubMed, Web of Science, and Scopus were systematically searched for studies that compared diabetes-related health outcomes between pre-pandemic and during-pandemic periods in people with T2DM and without the COVID-19 infection and published from January 1, 2020, to July 13, 2022. A meta-analysis was performed to estimate the overall effect on the diabetes indicators, including hemoglobin A1c (HbA1c), lipid profiles, and weight control, with different effect models according to the heterogeneity.

Results

Eleven observational studies were included in the final review. No significant changes in HbA1c levels [weighted mean difference (WMD), 0.06 (95% CI −0.12 to 0.24)] and body weight index (BMI) [0.15 (95% CI −0.24 to 0.53)] between the pre-pandemic and during-pandemic were found in the meta-analysis. Four studies reported lipid indicators; most reported insignificant changes in low-density lipoprotein (LDL, n = 2) and high-density lipoprotein (HDL, n = 3); two studies reported an increase in total cholesterol and triglyceride.

Conclusions

This review did not find significant changes in HbA1c and BMI among people with T2DM after data pooling, but a possible worsening in lipids parameters during the COVID-19 pandemic. There were limited data on long-term outcomes and healthcare utilization, which warrants further research.


Persistent Identifierhttp://hdl.handle.net/10722/331034
ISSN
2021 Impact Factor: 2.567
2020 SCImago Journal Rankings: 0.743

 

DC FieldValueLanguage
dc.contributor.authorHu, ZR-
dc.contributor.authorYoun, HM-
dc.contributor.authorQuan, JC-
dc.contributor.authorLee, LLS-
dc.contributor.authorMak, IL-
dc.contributor.authorYu, YET-
dc.contributor.authorChao, DVK-
dc.contributor.authorKo, WWK-
dc.contributor.authorWong, ICK-
dc.contributor.authorLau, GKK-
dc.contributor.authorLau, CS-
dc.contributor.authorLam, CL-
dc.contributor.authorWan, EYF-
dc.date.accessioned2023-09-21T06:52:12Z-
dc.date.available2023-09-21T06:52:12Z-
dc.date.issued2023-03-01-
dc.identifier.citationPrimary Care Diabetes, 2023, v. 17, n. 3, p. 229-237-
dc.identifier.issn1751-9918-
dc.identifier.urihttp://hdl.handle.net/10722/331034-
dc.description.abstract<h3>Background</h3><p>The effect directly from the coronavirus disease 2019 (COVID-19) infection on health and fatality has received considerable attention, particularly among people with type 2 diabetes mellitus (T2DM). However, evidence on the indirect impact of disrupted healthcare services during the pandemic on people with T2DM is limited. This systematic review aims to assess the indirect impact of the pandemic on the metabolic management of T2DM people without a history of COVID-19 infection.</p><h3>Methods</h3><p>PubMed, Web of Science, and Scopus were systematically searched for studies that compared diabetes-related health outcomes between pre-pandemic and during-pandemic periods in people with T2DM and without the COVID-19 infection and published from January 1, 2020, to July 13, 2022. A meta-analysis was performed to estimate the overall effect on the diabetes indicators, including hemoglobin A1c (HbA1c), lipid profiles, and weight control, with different effect models according to the heterogeneity.</p><h3>Results</h3><p>Eleven observational studies were included in the final review. No significant changes in HbA1c levels [weighted mean difference (WMD), 0.06 (95% CI −0.12 to 0.24)] and body weight index (BMI) [0.15 (95% CI −0.24 to 0.53)] between the pre-pandemic and during-pandemic were found in the meta-analysis. Four studies reported lipid indicators; most reported insignificant changes in low-density lipoprotein (LDL, n = 2) and high-density lipoprotein (HDL, n = 3); two studies reported an increase in total cholesterol and triglyceride.</p><h3>Conclusions</h3><p>This review did not find significant changes in HbA1c and BMI among people with T2DM after data pooling, but a possible worsening in lipids parameters during the COVID-19 pandemic. There were limited data on long-term outcomes and healthcare utilization, which warrants further research.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofPrimary Care Diabetes-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCOVID-19-
dc.subjectHemoglobin A1c-
dc.subjectIndirect effect-
dc.subjectMeta-analysis-
dc.subjectSystematic review-
dc.subjectType 2 diabetes mellitus-
dc.titleThe indirect impact of the COVID-19 pandemic on people with type 2 diabetes mellitus and without COVID-19 infection: Systematic review and meta-analysis-
dc.typeArticle-
dc.identifier.doi10.1016/j.pcd.2023.02.006-
dc.identifier.scopuseid_2-s2.0-85149698843-
dc.identifier.volume17-
dc.identifier.issue3-
dc.identifier.spage229-
dc.identifier.epage237-
dc.identifier.issnl1878-0210-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats